We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+1.77%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$19.4B
AUM Growth
+$60.4M
(+0.31%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
40.51%
Holding
261
New
8
Increased
55
Reduced
97
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$52.3M |
| 2 |
UnitedHealth
UNH
|
+$42.6M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$38.5M |
| 4 |
Broadridge
BR
|
+$35.7M |
| 5 |
Amazon
AMZN
|
+$32.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$110M |
| 2 |
Kraft Heinz
KHC
|
+$50.2M |
| 3 |
Plains All American Pipeline
PAA
|
+$43.7M |
| 4 |
Altria Group
MO
|
+$38.5M |
| 5 |
Constellation Brands
STZ
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.61% |
| 2 | Financials | 19.63% |
| 3 | Technology | 14.26% |
| 4 | Energy | 12.5% |
| 5 | Healthcare | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kinder Morgan
KMI
$70.9B
| $288M | 1.48% |
13,952,247
-242,761
| -2% | -$4.98M |
|
27
Johnson & Johnson
JNJ
$640B
| $269M | 1.39% |
2,082,894
+3,383
| +0.2% | +$446K |
|
28
Merck
MRK
$322B
| $261M | 1.35% |
3,254,744
+24,150
| +0.7% | +$1.94M |
|
29
Estee Lauder
EL
$30.4B
| $258M | 1.33% |
1,295,754
-25,371
| -2% | -$4.85M |
|
30
AbbVie
ABBV
$465B
| $249M | 1.28% |
3,288,503
-62,150
| -2% | -$4.26M |
|
|
NVO
31
Novo Nordisk
NVO
$228B
| $234M | 1.2% |
9,039,648
+69,692
| +0.8% | +$1.76M |
|
|
EV
32
DELISTED
Eaton Vance Corp.
EV
| $232M | 1.2% |
5,160,000
| – | – |
|
|
33
Amazon
AMZN
$2.44T
| $228M | 1.18% |
2,628,320
+347,060
| +15% | +$32.2M |
|
34
American Express
AXP
$224B
| $226M | 1.17% |
1,911,697
-54,748
| -3% | -$6.71M |
|
35
Blackrock
BLK
$167B
| $221M | 1.14% |
495,188
+20,245
| +4% | +$9.02M |
|
36
RTX Corp
RTX
$290B
| $182M | 0.94% |
2,113,076
+96,420
| +5% | +$8.01M |
|
37
Linde
LIN
$236B
| $172M | 0.89% |
888,050
-13,339
| -1% | -$2.58M |
|
38
Automatic Data Processing
ADP
$109B
| $160M | 0.82% |
988,811
+5,012
| +0.5% | +$828K |
|
|
39
UnitedHealth
UNH
$382B
| $158M | 0.81% |
727,400
+176,643
| +32% | +$42.6M |
|
40
Air Products & Chemicals
APD
$65.5B
| $157M | 0.81% |
709,551
+22,185
| +3% | +$4.99M |
|
41
ConocoPhillips
COP
$144B
| $142M | 0.73% |
2,495,495
-9,875
| -0.4% | -$562K |
|
42
Canadian Pacific Kansas City
CP
$81B
| $139M | 0.72% |
3,130,245
+24,415
| +0.8% | +$1.15M |
|
43
Intuitive Surgical
ISRG
$127B
| $132M | 0.68% |
732,576
+111,234
| +18% | +$19.2M |
|
44
ASML
ASML
$596B
| $119M | 0.61% |
479,891
-3,601
| -0.7% | -$811K |
|
45
Walmart Inc
WMT
$909B
| $115M | 0.59% |
2,908,518
-10,386
| -0.4% | -$392K |
|
46
Nike
NKE
$64.1B
| $107M | 0.55% |
1,141,763
+23,612
| +2% | +$2.02M |
|
47
Intercontinental Exchange
ICE
$87.2B
| $104M | 0.54% |
1,127,125
-8,560
| -0.8% | -$781K |
|
48
Diageo
DEO
$49.6B
| $92.9M | 0.48% |
568,010
-2,850
| -0.5% | -$477K |
|
49
Sherwin-Williams
SHW
$84.8B
| $92.9M | 0.48% |
506,655
+42,306
| +9% | +$7.2M |
|
50
Mastercard
MA
$498B
| $89.9M | 0.46% |
331,055
+31,103
| +10% | +$8.57M |
|
Similar funds
HF
Fayez Sarofim & Co's Q3 2019 Portfolio in Review
As of Q3 2019, Fayez Sarofim & Co held 261 positions worth $19.4B, up 0.31% from $19.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Fayez Sarofim & Co's Q3 2019 filing shows 8 new, 55 increased, 97 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,439 shares worth $2.92M. The largest sale was Enterprise Products Partners, an estimated $110M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- Fayez Sarofim & Co's largest Q3 2019 buy was Alibaba: 17,439 shares worth $2.92M.
- Fayez Sarofim & Co added most to Progressive in Q3 2019, an estimated $52.3M increase.
- Fayez Sarofim & Co's biggest Q3 2019 reduction was Enterprise Products Partners, cutting an estimated $110M.
- Fayez Sarofim & Co fully exited HSBC in Q3 2019, selling an estimated $406K.
- Fayez Sarofim & Co's ten largest holdings make up 41% of its $19.4B portfolio in Q3 2019.
- Fayez Sarofim & Co opened 8 new positions and closed 7 in Q3 2019.
- Fayez Sarofim & Co's portfolio value rose 0.31% quarter-over-quarter to $19.4B.
Based on Fayez Sarofim & Co's 13F filing for Q3 2019, filed 13 Nov 2019.